Insider Selling: Forescout Technologies Inc (FSCT) CFO Sells 7,957 Shares of Stock

Share on StockTwits

Forescout Technologies Inc (NASDAQ:FSCT) CFO Christopher Harms sold 7,957 shares of the stock in a transaction that occurred on Tuesday, December 11th. The stock was sold at an average price of $26.30, for a total transaction of $209,269.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Christopher Harms also recently made the following trade(s):

  • On Friday, November 9th, Christopher Harms sold 4,770 shares of Forescout Technologies stock. The stock was sold at an average price of $28.58, for a total transaction of $136,326.60.
  • On Thursday, October 11th, Christopher Harms sold 4,027 shares of Forescout Technologies stock. The stock was sold at an average price of $30.11, for a total transaction of $121,252.97.

Shares of NASDAQ:FSCT opened at $26.29 on Friday. Forescout Technologies Inc has a 1 year low of $22.80 and a 1 year high of $40.96. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.16 and a quick ratio of 2.16.

Forescout Technologies (NASDAQ:FSCT) last announced its earnings results on Thursday, November 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). Forescout Technologies had a negative net margin of 33.43% and a negative return on equity of 89.81%. The business had revenue of $85.63 million for the quarter, compared to analysts’ expectations of $79.08 million. During the same quarter last year, the business earned ($0.21) EPS. The company’s quarterly revenue was up 23.5% on a year-over-year basis. As a group, equities analysts forecast that Forescout Technologies Inc will post -1.95 earnings per share for the current year.

A number of equities research analysts have recently commented on FSCT shares. Monness Crespi & Hardt dropped their price objective on shares of Forescout Technologies from $43.00 to $40.00 and set a “buy” rating on the stock in a research note on Friday, November 9th. Zacks Investment Research raised shares of Forescout Technologies from a “hold” rating to a “buy” rating and set a $32.00 price objective on the stock in a research note on Tuesday, October 23rd. ValuEngine raised shares of Forescout Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, October 9th. Needham & Company LLC started coverage on shares of Forescout Technologies in a research note on Friday, September 21st. They set a “buy” rating and a $47.00 price objective on the stock. Finally, Berenberg Bank started coverage on shares of Forescout Technologies in a research note on Thursday, November 29th. They set a “buy” rating and a $41.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $39.73.

Several large investors have recently made changes to their positions in the company. BlackRock Inc. lifted its position in shares of Forescout Technologies by 2.2% during the 3rd quarter. BlackRock Inc. now owns 2,143,076 shares of the company’s stock valued at $80,923,000 after buying an additional 45,170 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Forescout Technologies by 8.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,243,773 shares of the company’s stock valued at $46,966,000 after purchasing an additional 97,273 shares in the last quarter. Vanguard Group Inc lifted its holdings in Forescout Technologies by 8.5% in the 3rd quarter. Vanguard Group Inc now owns 1,243,773 shares of the company’s stock valued at $46,966,000 after purchasing an additional 97,273 shares in the last quarter. Emerald Advisers Inc. PA lifted its holdings in Forescout Technologies by 45.1% in the 3rd quarter. Emerald Advisers Inc. PA now owns 896,677 shares of the company’s stock valued at $33,859,000 after purchasing an additional 278,766 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust lifted its holdings in Forescout Technologies by 52.0% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 822,721 shares of the company’s stock valued at $31,066,000 after purchasing an additional 281,425 shares in the last quarter. Hedge funds and other institutional investors own 56.15% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was posted by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://baseballnewssource.com/2018/12/16/insider-selling-forescout-technologies-inc-fsct-cfo-sells-7957-shares-of-stock/3085168.html.

About Forescout Technologies

ForeScout Technologies, Inc provides network security products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. It offers ForeScout CounterACT agentless technology that discovers, classifies, and assesses IP-based devices; ForeScout extended modules, which represent integrations across vulnerability assessment, advanced threat detection, security incidence and event management, enterprise mobility management, endpoint protection and endpoint detection and response, next generation firewall, privileged access management, and IT systems management vendors, as well as compliance; and ForeScout CounterACT Enterprise Manager, a centralized security management solution for the control of various appliances deployed on an end-customer network, as well as maintenance and professional services.

Recommended Story: How to Invest in a Bull Market

Insider Buying and Selling by Quarter for Forescout Technologies (NASDAQ:FSCT)

Receive News & Ratings for Forescout Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forescout Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.